Related Experiment Video

Updated: Jun 4, 2026

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

[Nosocomial infection caused by Pseudomonas aeruginosa in intensive care unit]

Yu-Qi Wu1, Hong-Wei Shan, Xian-Yu Zhao

  • 1The First People's Hospital, Yichang 443002, Hubei, China.

Zhongguo Wei Zhong Bing Ji Jiu Yi Xue = Chinese Critical Care Medicine = Zhongguo Weizhongbing Jijiuyixue
|February 15, 2011
PubMed
Abstract

Insights

Nosocomial infections caused by Pseudomonas aeruginosa in the ICU are linked to corticosteroid use and mechanical ventilation. Implementing targeted infection control measures for these factors is crucial for prevention.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Microbiology

Context:

  • Intensive care units (ICUs) are high-risk environments for nosocomial infections.
  • Pseudomonas aeruginosa is a significant opportunistic pathogen in critically ill patients.
  • Understanding specific risk factors is essential for effective infection control strategies.

Purpose:

  • To identify independent risk factors for nosocomial infections caused by Pseudomonas aeruginosa in the ICU.
  • To provide data for developing targeted prevention and control measures.
  • To analyze clinical data from a retrospective cohort.

Summary:

  • A retrospective study analyzed 1,950 ICU patients from 2002-2006 to identify risk factors for Pseudomonas aeruginosa infections.
  • Multivariable logistic regression identified corticosteroid use and mechanical ventilation as independent risk factors.
  • The study highlights the need for specific interventions targeting these factors to reduce infection rates.

Impact:

  • Findings can inform clinical practice and hospital infection control policies.
  • Reduced incidence of Pseudomonas aeruginosa ICU infections can improve patient outcomes.
  • This research contributes to the broader understanding of antibiotic-resistant bacterial infections in critical care settings.

More Related Videos

Pseudomonas aeruginosa Induced Lung Injury Model07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model07:39

Tools for the Real-Time Assessment of a Pseudomonas aeruginosa Infection Model

Published on: April 6, 2021

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: